Defective Rac-mediated proliferation and survival after targeted mutation of the β1 integrin cytodomain by Hirsch, Emilio et al.
 

 
 The Rockefeller University Press, 0021-9525/2002/04/481/12 $5.00
The Journal of Cell Biology, Volume 157, Number 3, April 29, 2002 481–492
http://www.jcb.org/cgi/doi/10.1083/jcb.200111065
 
JCB
 
Article
 
481
 
Defective Rac-mediated proliferation and survival 
 
after targeted mutation of the 
 
 
 
1
 
 integrin cytodomain
 
Emilio Hirsch,
 
1,2
 
 Laura Barberis,
 
1 
 
Mara Brancaccio,
 
1
 
 Ornella Azzolino,
 
1
 
 Dazhong Xu,
 
5
 
 John M. Kyriakis,
 
5
 
 
Lorenzo Silengo,
 
1,2
 
 Filippo G. Giancotti,
 
6 
 
Guido Tarone,
 
1,2
 
 Reinhard Fässler,
 
3,4 
 
and Fiorella Altruda
 
1,2
 
1
 
Dipartimento di Genetica, Biologia, e Biochimica, Università di Torino, 10126 Torino, Italy
 
2
 
Experimental Medicine Research Center, San Giovanni Battista Hospital, 10126 Torino, Italy
 
3
 
Max-Planck Institute for Biochemistry, 8285 Martinsried, Germany
 
4
 
Department of Experimental Pathology, Lund University Hospital, S-222 85 Lund, Sweden
 
5
 
Diabetes Research Laboratory, Medical Services, Massachusetts General Hospital, Boston, MA 02129
 
6
 
Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021
 
ell matrix adhesion is required for cell proliferation
and survival. Here we report that mutation by gene
 
targeting of the cytoplasmic tail of 
 
 
 
1
 
 integrin leads
to defective proliferation and survival both in vivo and in
vitro. Primary murine embryonic ﬁbroblasts (MEFs) derived
from mutant homozygotes display defective cell cycle
coupled to impaired activation of the FAK-PI3K-Akt and
Rac-JNK signaling pathways. Expression in homozygous
MEFs of a constitutively active form of Rac is able to rescue
proliferation, survival, and JNK activation. Moreover, although
C
 
showing normal Erk phosphorylation, mutant cells fail to
display Erk nuclear translocation upon ﬁbronectin adhesion.
However, expression of the constitutively activated form
of Rac restores Erk nuclear localization, suggesting that
adhesion-dependent Rac activation is necessary to integrate
signals directed to promote MAPK activity. Altogether, our
data provide the evidence for an epistatic interaction between
the 
 
 
 
1
 
 integrin cytoplasmic domain and Rac, and indicate
that this anchorage-dependent signaling pathway is crucial
for cell growth control.
 
Introduction
 
Modulation of cell adhesion is known to influence essential
cellular processes such as proliferation, differentiation, and
migration. Major molecular mediators of these effects are in-
tegrins, heterodimeric transmembrane glycoproteins able to
link extracellular matrix components and intracellular actin
cytoskeleton. Integrins are formed by 
 
 
 
 and 
 
 
 
 subunits
which act together (Hynes, 1992). So far, 8 
 
 
 
 and 18 
 
 
 
 sub-
units have been described, and the 
 
 
 
1
 
 subunit is contained
in 11 receptors with distinct 
 
 
 
 chains. The 
 
 
 
1
 
 subunit is also
present in alternatively spliced isoforms of the cytoplasmic
C-terminal tail. Murine cells express a ubiquitous A and a
muscle-specific D isoform (Belkin et al., 1996).
By binding to a large variety of interactors (Hemler, 1998;
Liu et al., 2000), the short cytoplasmic sequence of all 
 
 
 
1
 
variants regulates several kind of transmembrane signaling
events (Sastry and Horwitz, 1993). The most membrane
proximal segment is encoded by a single exon (exon 6) that
is shared by all 
 
 
 
1
 
 splice variants; it spans 25 amino acids
able to interact with focal adhesion kinase (FAK),* paxillin,
 
 
 
-actinin, and melusin (Otey et al., 1993; Schaller et al.,
1995; Brancaccio et al., 1999). On the other hand, each
splice variant is characterized by the presence of distinct
C-terminal ends. Amino acids of the 
 
 
 
1A
 
-specific tail bind
cytoskeletal components like talin and filamin (Pfaff et al.,
1998) or signaling effectors like ICAP1 (Chang et al., 1997;
Degani et al., 2002) and ILK (Dedhar and Hannigan, 1996)
(Fig. 1).
The wide variety of cell adhesion events mediated by 
 
 
 
1
 
integrins is crucial in vivo and essential for mammalian de-
 
velopment (Fässler et al., 1996). Studies of anchorage-
dependent cell growth suggest that integrins, together with
growth factor receptors, activate mitogen-activated protein
kinases and thus allow cell cycle progression. Adhesion to
the extracellular matrix leads to the 
 
 
 
 integrin subunit-
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dependent activation of Fyn, and to the subsequent recruit-
ment of Shc (Giancotti and Ruoslahti, 1999). In addition,
the 
 
 
 
 integrin subunit is involved in the activation of the ty-
rosine kinase FAK. Both pathways are able to link adhesive
events to the phosphorylation of Erk by activating Ras via
direct binding of either FAK or Shc to Grb2 (Schlaepfer et
al., 1994; Wary et al., 1996). Recently, it has been shown
that FAK can also activate Erk through a mechanism involv-
ing B-Raf and Rap1 (Barberis et al., 2000). Although con-
certed Erk activation by adhesion and growth factors is con-
sidered necessary for Cyclin D1 induction (Roovers et al.,
1999), some reports indicate that other adhesion-mediated
signals are required for cell cycle progression (Le Gall et al.,
1998). For example, in parallel to Erk activation, integrins
trigger signals that allow the coupling of the Rac GTPase to
its downstream effectors (del Pozo et al., 2000; Mettouchi et
al., 2001).
Using a gene-targeting strategy in embryonic stem (ES)
cells, we have isolated a 
 
 
 
1
 
 integrin allele encoding a mutant
cytoplasmic domain (
 
 
 
1de6
 
 allele) in which the alternatively
spliced C-terminal sequence was substituted with 11 amino
acids unrelated to all known 
 
 
 
1
 
 splice variants. Homozygous
mice die between embryonic day 10.5 and 11.5. Moreover,
mutant embryos show impaired cell proliferation and sur-
vival. Primary murine embryonic fibroblasts (MEFs) derived
from mutant homozygotes display normal adhesion to fi-
bronectin (Barberis et al., 2000) but exhibit strongly im-
paired integrin-mediated activation of PI3K, Rac, and JNK.
In addition, mutant MEFs, although presenting normally
phosphorylated Erk (Barberis et al., 2000), fail to translocate
Erk into the nucleus. Erk nuclear localization, JNK activa-
Figure 1.  Known and inferred interactions of the  1 cytoplasmic 
domain. Amino acids replaced in the  1de6 are boxed. See Hemler 
(1998) and Liu et al. (2000) for binding sites.
Figure 2. Structure of the  1de6 locus. (A) Schematic representation of the  1 integrin wild-type allele, of the targeting vector, and of the 
resulting  1de6 locus. Closed boxes represent  1 integrin exon 5, 6, and the alternatively spliced exon D and A. The size of introns is indicated. 
The solid arrows and bar below the  1de6 locus indicate the primers used for genomic amplification and the size of the resulting PCR product. 
The vertical arrowhead indicates the insertion site of the 5  of the construct. K, KpnI; H, HinDIII; P, ApaI; X, XbaI. (B) Southern blot analysis of 
targeted ES cells. Genomic DNA was digested with XbaI. The targeted clone shows two bands corresponding to wild-type and mutant alleles, 
as expected after homologous recombination. (C) Exon 6 is duplicated in  1de6 cells. Genomic PCR with primers shown in panel a confirm the 
insertion of the mutant exon 6 downstream of its wild-type counterpart. (D) RT-PCR assay. In the heterozygous  1de6 RNA, primers on  1 
integrin exon 5 and exon 6 amplify two fragments corresponding to the wild-type (exons 5 and 6; 130 bp) and the mutant (exons 5 and 
6; mutant exon 6; 296 bp) mRNAs. Splicing of exon 6 to its duplicate causes a frameshift mutation and the substitution of the alternatively 
spliced C-terminal tail with 11 amino acids irrelevant to  1 integrin sequences. M:1kb ladder (GIBCO BRL). 
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tion, and proliferation and survival are rescued by a constitu-
tively active form of Rac, showing that 
 
 
 
1
 
 integrin–induced
Rac activation is a crucial step for anchorage-dependent con-
trol of cell growth.
 
Results
 
Targeted mutation of the 
 
 
 
1
 
 integrin 
cytoplasmic domain
 
A 
 
 
 
1
 
 integrin cytoplasmic domain mutant allele (
 
 
 
1de6
 
) was
obtained by gene targeting in murine ES cells. This allele
was found in a single targeted clone, and consequently to a
unique recombination event carried the duplication of exon
6 as indicated in Fig. 2. This structure lead to the expression
of a 
 
 
 
1
 
 subunit in which the cytoplasmic sequence shared by
all 
 
 
 
1
 
 integrin splice variants was followed by an irrelevant
C-terminal tail sequence, consisting of 11 amino acids (with
a predicted sequence: TVLLVPTSSQL) unrelated to all
known 
 
 
 
1
 
 integrin isoforms.
 
Homozygosity for the 
 
 
 
1de6
 
 allele leads 
to embryonic lethality
 
ES cells deriving from the targeted clone carrying the 
 
 
 
1de6
 
allele were injected into C57B6 host blastocysts, and germ
line transmitting chimeras were generated. Heterozygous an-
imals were viable and fertile. Histology of various tissues
from these animals did not show any abnormality. Genotyp-
ing of litters derived from heterozygotes crosses showed that
among 672 pups, 448 were heterozygous and 224 were
wild-type homozygous. These results were consistent with a
recessive embryonic lethal phenotype caused by homozygos-
ity for the 
 
 
 
1de6
 
 allele.
 
Embryos derived from heterozygous intercrosses were dis-
sected and genotyped by PCR. Homozygous mutants that were
exteriorly indistinguishable from wild-type littermates could be
identified until 8.5 d postcoitum (dpc). Later, 
 
 
 
1de6
 
/
 
 
 
1de6
 
 em-
bryos started to exhibit retarded growth and a plethora of vari-
ably combined abnormalities. At 9.5 dpc, 50% of the mutant
homozygous embryos showed the failure of the allantois to fuse
with the chorion (Fig. 3, A and B). Histology of 9.5-dpc 
 
 
 
1de6
 
homozygotes indicated that when the allantois was not fused to
the chorion, embryos appeared abnormally oriented in the de-
cidua (Fig. 3, C–E). At 10.5 dpc, 95% of mutants displayed
cardiac and/or craniofacial abnormalities. Heart disfunction was
suggested by the presence of pericardiac effusion (Fig. 3, F and
G). The severity of this phenotype was variable and ranged
from mild liquid accumulation in the pericardial cavity to se-
vere developmental retardation and pericardial swelling. In ad-
dition, mutants showed exencephaly (20% penetrance; Fig. 3
H) and/or abnormally waved or kinky neural tube (90% pene-
trance; Fig. 3 J). Moreover, mutant embryos exhibited blood
leakage in the yolk sac, delayed somite development, and de-
creased density of mesenchymal cells (Fig. 3 J). At 11.5 dpc,
mutant embryos showed no heart beating, appeared much
smaller than wild-type littermates, and were already in process
of being resorbed. At 12.5 dpc, no 
 
 
 
1de6
 
 homozygotes could be
detected, and 
 
 
 
1/4 of the implantation sites contained only
blood. Identical results were obtained from the analysis of both
C57/129Sv mixed genotype and 129Sv inbred intercrosses.
 
The 
 
 
 
1de6
 
 allele encodes a single 
 
 
 
1
 
 integrin isoform 
which retains the ability to localize into focal contacts
 
To analyze whether 
 
 
 
1de6
 
 homozygous embryos were still
able to express 
 
 
 
1
 
 integrin variants, RT-PCR analysis was
Figure 3. Phenotypic analysis of  1de6 homozygous embryos. (A–D) Whole-mount wild-type (A and C) and mutant (B and D) embryos are 
shown at 9.5 (A and B) and 10.5 (C and D) dpc (B) Mutant embryo displaying defective placentation. (D) Mutant embryos showing normal 
chorion-allantois fusion but cardiac defects. A reduction of the anterior-posterior axis and a significant disconnection between myocardium 
and pericardium is visible. (E–G) Histological analysis of 9.5-dpc embryos. (E) Wild-type embryo. (F and G) Mutant embryo showing lack of 
chorion–allantois fusion. Note that allantois and chorion are located on distinct planes and oppositely oriented. (H) Transverse section of the 
head of a  1de6 homozygous embryo at 10.5 dpc showing hindbrain exencephaly and lack of chorion-allantois fusion. (I) Section of the 
posterior trunk of a 10.5-dpc wild-type embryo. Somites already show differentiated dermomyotome and sclerotome. (J) Section of the back 
of a corresponding mutant embryo, showing retarded somite development and subsequent reduction of mesenchymal cells. Of note is the 
presence of hemorrhage in the exocoelom. a, atrium; al, allantois; am, amnion; b, primordial blood cells; ba, branchial arch; c, chorion; cn, 
caudal neuropore; da, dorsal aorta; dm, demomyotome component of somite; f, pharynx; h, heart; ivf, inter-ventricular foramen; mc, myelocoel; 
om, open myelencephalon; p, placenta; pc, pericardium; s, somites; sc, spinal cord; st, sclerotome component of somite; t, telencephalon; tv, 
telencephalic vescicle; u, umbilical stalk; uv, umbilical vessels; v, ventricle; ys, yolk sac. Bars: (A–H) 1 mm; (I) 200  m. 
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performed to detect the presence of the 
 
 
 
1A
 
 and 
 
 
 
1D
 
 tran-
scripts. Total RNA was extracted from mutant and wild-
type embryos (9.5 dpc) and, as shown in Fig. 4 A, 
 
 
 
1A
 
 and
 
 
 
1D
 
 could be amplified from wild-type RNA but not from
 
 
 
1de6
 
 homozygous samples.
The expression of the mutant protein was analyzed by es-
tablishing cultures of MEFs isolated from 9.5 dpc embryos.
To test the expression of the mutant integrin, the surface of
wild-type and mutant MEFs was biotinylated, and extracts
were immunoprecipitated using a polyclonal antiserum that
recognized the 
 
 
 
1A
 
-specific sequence. As indicated in Fig. 4
B (left), 
 
 
 
1A
 
 could be immunoprecipitated uniquely from
wild-type cells. In contrast, a 
 
 
 
1
 
 integrin extracellular epi-
tope could be detected in MEFs of both genotypes (Fig. 4 B,
right). These data indicate that 
 
 
 
1de6
 
 homozygous cells ex-
pressed a single 
 
 
 
1
 
 integrin isoform carrying a mutant cyto-
plasmic domain. The alteration of the 
 
 
 
1 C-terminal tail was
previously associated with defective recruitment of the pro-
tein into focal contacts. Nevertheless, in agreement with a
crucial role of   subunits for integrin targeting to focal adhe-
sions, immunofluorescence with anti-vinculin and anti- 1
antibodies showed that, in mutant MEFs plated on fi-
bronectin,  1de6 distributed in focal contacts as efficiently as
wild-type  1 (Fig. 4, C–F).
Altogether, these data demonstrate that  1de6 is the only
 1 integrin isoform expressed by homozygous mutant MEFs
and that the altered cytoplasmic domain does not interfere
with its correct cellular distribution.
 1de6 homozygotes and derived MEFs show impaired 
proliferation and survival
Integrin-mediated signaling is thought to control anchorage-
dependent cell growth; thus, it is possible that  1de6 affects
cell proliferation and survival. To test this hypothesis in vivo
without being biased by a general defective growth due
to abnormal materno-fetal circulation, 8.5-d-old embryos
showing heart beating and normal placentation were stud-
ied. Counts of BrdU-labeled nuclei in wild-type and mutant
embryos showed a small but significant 10% decrease of
proliferating cells in  1de6 homozygotes (wild-type tissue:
82   6 BrdU-labeled nuclei/total nuclei per field *100, n  
574; mutant tissue: 74   6, n   591 – values expressed as
mean   SD; P   0.01 by Student’s t test). Strikingly, older
embryos (9.5 dpc) showed a higher reduction of BrdU stain-
ing which was particularly evident in the mesenchyme (Fig.
5, A and B), where mutant cells exhibited a 30% decrease in
the number of labeled nuclei (wild-type tissue: 47   10
BrdU labeled nuclei/total nuclei per field *100, n   8213;
mutant tissue: 32   9, n   7433 – values expressed as
mean   SD; P   0.03 by Student’s t test). In addition, de-
tection by TdT-mediated dUTP-biotin nick end labeling
(TUNEL) assay of apoptotic cells in sections of 9.5 dpc em-
bryos revealed that mutant homozygotes also showed signifi-
cantly higher numbers of TUNEL-positive cells in the mes-
enchyme and heart (Fig. 5, C and D).
Consistent with these findings,  1de6 homozygous MEFs
showed a modified cell cycle profile. Whereas analysis of
DNA content by FACS of synchronized mutant cells dis-
played a modest but statistically significant increase of cells in
G1 (25% increment), the number of cells in S phase was low-
ered by 30% and cells in G2 were strongly reduced (76% de-
crease; Fig. 5 E). Moreover, testing of MEFs for adhesion-
dependent cell proliferation indicated reduced numbers of
BrdU labeled cells in cultures of mutant cells (Fig. 5 F). Inter-
estingly, this proliferation defect was maximal on the  1 inte-
grin ligand fibronectin but not on the  3 ligand vitronectin,
thus showing the specificity of the defect (Fig. 5 F). Altogether,
these data suggested that  1de6 homozygous MEFs were charac-
terized by an impaired or delayed G1/S transition. In agree-
ment with this hypothesis, synchronized cultures showed that
clearance of the cyclin dependent kinase inhibitor p27
kip1 to-
gether with accumulation of cyclin D1 occurred more slowly
in mutant cells than in wild-type controls (Fig. 5 G).
In addition, in vitro analysis revealed in mutant MEFs re-
duced adhesion-mediated cell survival (Fig. 5 H). Consistent
with these results, detection of caspase-3 activation in vivo
(Fig. 5 I) exhibited, in  1de6 homozygous embryos, a signifi-
cant decrease of inactive procaspase-3 and a concomitant in-
crement of cleaved active caspase-3. These results demon-
strate that the expression of  1de6 mutant integrin likely
impairs anchorage-dependent signaling events that sustain
cell proliferation and survival.
The adhesion-triggered PI3K-dependent survival 
pathway is impaired in  1de6 homozygous MEFs
Previous results revealed that  1de6 homozygous MEFs
normally adhere to fibronectin but are not able to acti-
vate the tyrosine kinase FAK (Barberis et al., 2000). Be-
Figure 4. Integrin expression in  1de6 
homozygous MEFs. (A) RT-PCR analysis 
of  1A and  1D splice variants in wild-
type (WT) and  1de6 homozygous ( 1de6) 
MEFs. A fragment of the actin (act) 
mRNA is coamplified as an internal 
control. (B) Immunoprecipitation of 
biotinylated cell surface  1 integrins. 
Extracts from wild-type (WT) and 
homozygous mutant ( 1de6) MEFs
were immunoprecipitated with an
antibody recognizing the  1A-specific 
cytodomain (left). The supernatant 
was subsequently immunoprecipitated 
with an antibody recognizing the  1 
integrin extracellular portion (right panel). (C–F) Immunolabeling of wild-type (C and E) and mutant (D and F) MEFs. Vinculin (C and D) 
and  1 integrin subunit (E and F) staining are shown. Bars, 10  m.In vivo study of a  1 integrin cytodomain mutant | Hirsch et al. 485
cause FAK activity has been shown to regulate PI3K, a
molecule involved in controlling proliferation and sur-
vival, we investigated whether the presence of  1de6 could
interfere with adhesion-dependent PI3K activation. First,
the ability of p85 PI3K regulatory subunit to coimmuno-
precipitate with FAK was tested after adhesion to fi-
bronectin. As shown in Fig. 6 A, recruitment of p85 to a
FAK-containing complex was strongly reduced in  1de6/
 1de6 cells.
Next, PI3K activity induced by adhesion to fibronectin
was tested by analyzing phosphorylation of the PI3K-depen-
dent downstream target PKB/Akt. As shown in Fig. 6 C,
whereas in wild-type cells PKB/Akt was activated by the ad-
hesive stimulus, in  1de6 homozygous cells PKB/Akt phos-
phorylation was undetectable. Because activation of PI3K is
crucial for PKB/Akt phosphorylation, these data strongly
suggest that the  1 integrin cytoplasmic domain plays a cru-
cial role in FAK-dependent PI3K activation.
 1de6 affects Rac-dependent signaling
In fibroblasts, integrins contribute to the activation of the
small GTPase Rac by triggering multiple signaling path-
ways, such as p130Cas/Crk/DOCK180 (Kiyokawa et al.,
1998), PI3K/SOS (Mettouchi et al., 2001), and possibly
paxillin activation (Igishi et al., 1999). Interestingly, analysis
of adhesion-stimulated cells showed that paxillin phosphos-
phorylation is delayed and reduced in  1de6 homozygous
MEFs (Fig. 6 D). Together with this observation, the lack of
adhesion-stimulated activation of PI3K along with the pre-
vious observation that signaling through p130Cas is blocked
(Barberis et al., 2000) suggested that, in mutant cells, Rac
activation could be impaired. Indeed, pulldown assays using
the CRIB domain of PAK-1 fused to GST revealed that, af-
ter plating  1de6 homozygous MEFs on fibronectin, Rac acti-
vation was heavily impaired both in the absence (Fig. 7 A)
and in the presence (Fig. 7 B) of growth factors. Accordingly
to this result, mutant cells analyzed by immunofluorescence
at 30 min after fibronectin adhesion in the presence of
growth factors showed decreased lamellipodia formation
(Fig. 7 C).
Downstream, Rac stimulates the activation of JNK, a
stress-activated protein kinase (SAPK) known to control cell
proliferation and survival (Leppa and Bohmann, 1999). Ac-
tivation of JNK and of another SAPK, p38, was thus exam-
ined in  1de6 homozygous MEFs. As shown in Fig. 7, D and
E, plating on fibronectin stimulates the phosphorylation of
Figure 5. Impaired proliferation and apoptosis in  1de6 homozygous 
embryos. (A–D) Sections of wild-type (A and C) and mutant (B and 
D) 9.5 dpc embryos marked for BrdU (A and B) and TUNEL (C and 
D). Bars, 100  m. (E) Comparison of propidium iodide fluorescence 
peaks derived from nuclear DNA analysis of wild-type (white curve) 
and  1de6 homozygous (black curve) MEFs after 8 h of adhesion 
fibronectin in the presence of growth factors. Note the strong 
reduction of  1de6 homozygous MEFs in the G2/M cell cycle phase. 
(F) BrdU incorporation in wild-type (white bars) and mutant (black 
bars) MEFs. Proliferation was impaired in mutant MEFs after adhesion 
to the  1 integrin ligand fibronectin (FN) but not to the  3 ligand 
vitronectin (VN). (G) Analysis, in wild-type and  1de6 homozygous 
MEFs, of p27 and ciclyn D1 after 3, 8, and 13 h of fibronectin 
adhesion in the presence of growth factors. Equal loading is indicated 
by Src immunoblotting. (H) Quantitation of wild-type (white bar) 
and mutant (black bar) apoptotic MEFs. (I) Analysis of the amount 
of the pro-caspase3 and its cleaved forms in total extracts from 
10.5-dpc embryos. Data are representative of three (G and I) and 
four (E, F, and H) experiments.
Figure 6. Adhesion-dependent PI3K and paxillin activation. (A) 
Extracts from wild-type (WT) and mutant ( 1de6) MEFs, adhering to 
fibronectin for the given times, were immunoprecipitated with anti-
FAK antibodies and were revealed by Western blot analysis of Tyr-
phosphorylated FAK, p85 subunit of PI3K, and total FAK. (B) Detection 
of p85 in wild-type and mutant MEFs indicates identical expression 
levels. Equal loading was assayed by labeling with an anti–Src anti-
body. (C) Extracts from wild-type and mutant MEFs, adhering to 
fibronectin for the given times, were probed with anti PKB/Akt 
phosphorylated in Ser473, and total PKB/Akt. (D) After fibronectin 
adhesion, extracts derived from cells of the two genotypes were 
immunoprecipitated with an anti-paxillin antibody and revealed 
by Western blot analysis with the same anti-paxillin (paxillin) or 
with an anti-phosphotyrosine antibody (P-Tyr). (A–D) Data are 
representative of three experiments.486 The Journal of Cell Biology | Volume 157, Number 3, 2002
both JNK and p38. In contrast, these activation events were
undetectable in the mutant cells.
These data point to a crucial role for the C-terminal tail of
 1 integrin in the activation of Rac and the subsequent
phosphorylation of JNK.
Adhesion-activated Rac controls Erk subcellular 
localization and is essential for cell growth
To investigate whether impaired proliferation and survival
in  1de6 homozygous embryos were caused by defective Rac
activation, MEFs were infected with adenoviruses express-
ing a constitutively active (Rac
V12) or a dominant negative
(Rac
N17) form of Rac.
After expression of Rac
V12,  1de6 homozygous MEFs were
able to activate JNK as efficiently as wild-type cells. Inter-
estingly, Rac
V12 expression led to adhesion-independent JNK
activation: similar JNK phosphorylation could be de-
tected in both wild-type and mutant infected fibroblasts kept
in suspension. Conversely, wild-type fibroblasts expressing
Rac
N17 showed a strong reduction in activated JNK when
adhering to fibronectin (Fig. 8 B).
Next, proliferation and survival were tested by BrdU and
TUNEL assays in synchronized cell cultures of wild-type
and mutant MEFs expressing Rac
V12. As shown in Fig. 8, C
and D, the proliferation defect and the increased apoptosis
of mutant cells were completely rescued. On the other hand,
the presence of Rac
N17 in wild-type MEFs was sufficient to
cause the increased apoptosis and the reduced cell growth
exhibited by untreated mutant MEFs.
In addition to JNK, Erk 1 and 2 play a crucial role in
transducing mitogenic signals. MEFs homozygous for the
 1de6 allele normally phosphorylate Erk in response to a
combined stimulation by adhesion and growth factors (Bar-
beris et al., 2000); however, in a large majority of these cells
(85%; P    0.001 by  
2 test versus wild-type controls;
n   300 for each genotype) Erk nuclear translocation was
strongly impaired (Fig. 9). Accordingly, forced Erk phos-
phorylation in suspended cells is not sufficient for nuclear
translocation and activation of the transcription factor Elk
(Aplin et al., 2001). To investigate the nature of the inte-
grin-dependent signal required for Erk nuclear localization,
we next examined whether Rac played a role in this process.
Figure 7. Adhesion-mediated activation of Rac and SAPK. Data are representative of four experiments. (A) Detection of Rac bound to the 
GST-PAK-1 CRIB domain after fibronectin adhesion for the given times. (B) The same as A but in the presence of 0.2% FCS and 6.25  g/ml
insulin. (C) Analysis of lamellipodia (arrowheads) formation in wild-type (WT) and mutant ( 1de6) MEFs. Starved cells were plated on 
fibronectin for 30  in the same conditions as in B. Actin cytoskeleton and nuclei were evidenced by phalloidin-RITC and bisbenzimide staining, 
respectively. Bars, 10  m. (D–E) Analysis of p38 (D) and JNK (E) SAPKs phosphorylation in wild-type and mutant MEFs treated as in A. 
(F) Western blot analysis of JNK in wild-type and mutant MEFs indicates identical expression levels. Equal loading was assessed by labeling 
with an anti-Src antibody.In vivo study of a  1 integrin cytodomain mutant | Hirsch et al. 487
Strikingly, expression of Rac
V12 in  1de6 homozygous cells,
adhering to fibronectin in the presence of growth factors,
caused a strong enrichment of nuclear Erk; on the contrary,
expression of Rac
N17 in wild-type cells decreased amounts of
nuclear Erk (Fig. 9). Thus, integrin-dependent Rac activa-
tion is a critical step for Erk subcellular localization.
In conclusion, the findings presented here show an epi-
static interaction between the  1 integrin cytoplasmic do-
main and Rac and demonstrate that this signaling pathway,
by integrating JNK and Erk activation, plays an essential
role in anchorage-dependent cell cycle progression, as well as
cell survival.
Discussion
Our study demonstrates that, in  1de6 homozygous mice,
mutation of the C-terminal tail of the  1 integrin subunit
causes in vivo and in vitro defective adhesion-dependent cell
proliferation and survival and ultimately a recessive embry-
onic lethal phenotype.
Homozygous   1de6 embryos developed to midgestation
but then died showing multiple variably penetrant pheno-
types. Although these phenotypes could be analyzed in mice
derived from a single ES clone, the chance that they were
caused by a clonal artifact is very unlikely. In fact, they ap-
peared stable and reproducible  30 generations in two dis-
tinct genetic backgrounds (inbred 129Sv and mixed 129Sv/
C57B6), as well as after 10 generations of backcrossing with
C57B6 mice. This stability, after such a dilution of the orig-
inal ES clone genotype, supports the direct involvement of
the  1de6 mutation in the reported phenotypes.
Interestingly,  1de6 homozygous embryos were found to
survive longer than  1-null mutants which die around em-
bryonic day 5 (Fässler et al., 1996). Because the  1 integrin
cytoplasmic domain consists of a C-terminal tail that is sub-
jected to alternative splicing and of a common juxtamem-
brane tract that is present in  1de6 and all  1 splice variants,
our data suggest that the alternatively spliced region of the
 1 cytoplasmic domain is dispensable in early morphoge-
netic processes. Likewise, our results indicate that the mem-
brane proximal subdomain still present in the  1de6 integrin
is sufficient to generate the signals and/or cytoskeletal link-
age required for these events. Consistently, mice ectopically
expressing  1D, a muscle-specific splicing variant which also
contains the wild-type common cytodomain, survive be-
yond implantation but die before birth because of variably
penetrant phenotypes that, like in  1de6 homozygotes, in-
clude vascular and neuroepithelial malformations (Baudoin
et al., 1998).
The presence in  1de6 homozygous embryos of vascular
abnormalities and defective placentation suggests that this
might be the reason for the lethality. Similar defects are the
major causes of the death of mutant embryos lacking dis-
tinct integrin   subunits like  4 and  5 (for review see
Brakebusch et al., 1997). For example, the aberrant mesen-
chyme development (Fig. 3 J) and the leaking blood islands
(Fig. 3, G and J) seen in  1de6 homozygotes have been simi-
larly detected in  5-deficient embryos (Yang et al., 1993).
However, the overall phenotype of  1de6 homozygotes, al-
though sharing some characteristics of the  5-null embryos,
strongly overlaps with that of  4-null mutants. In fact, like
 1de6/ 1de6 embryos, mice lacking the  4 integrin subunit die
at embryonic day 11, showing variably penetrant pheno-
types such as heart abnormalities and absence of chorion-
allantois fusion (Yang et al., 1995). Although the explana-
tion for this correspondence is not clear, on the basis that
distinct   integrin subunits show distinct biological proper-
ties, bind different intracellular proteins (Hemler, 1998; Liu
Figure 8. Effects on cell proliferation 
and survival induced by expression of 
Rac
V12 and Rac
N17. (A) Expression of 
endogenous (Co) and exogenous Rac in 
MEFs infected with the constitutively 
active (V12) and the dominant negative 
(N17) forms of Rac. Infection with 
recombinant adenoviruses did not cause 
E1A viral protein expression. (B) Rac-
dependent rescue of JNK phosphorylation 
in mutant MEFs after 30  of fibronectin 
adhesion (Adh) or suspension (S). (C) 
Evaluation of cell proliferation by BrdU 
incorporation in wild-type (white bars) 
and  1de6 homozygous (black bars) 
MEFs. Proliferation (Co) was impaired in 
mutant MEFs after adhesion to the  1 
integrin ligand fibronectin (FN) but not 
to the  3 ligand vitronectin (VN). Infec-
tion with an adeno-GFP viral vector did 
not influence this effect (GFP). Expression 
of Rac
V12 rescued the defect. (D) In vitro 
analysis of apoptosis. Expression of 
Rac
V12 rescued mutant cells (black bars) 
from apoptosis, whereas the dominant 
negative form (N17) induced cell death 
in wild-type MEFs (white bars). Bar 
graphs represent means   SD of four
independent experiments.488 The Journal of Cell Biology | Volume 157, Number 3, 2002
et al., 2000) and specifically cooperate with the  1 cytodomain
for signaling (Sastry et al., 1999), it is tempting to speculate
that signaling of  4 more strongly requires the  1 C-terminal
tail than that of  5.
Despite the similarity between  1de6/   1de6 and  4-null
embryos, our analysis indicates that in vivo expression of
 1de6 leads to defective cell proliferation and survival inde-
pendently of the vascular phenotypes. In fact, decreasing
numbers of dividing cells and increased apoptosis could be
detected in  1de6 homozygous embryos that showed normal
placentation and still had an apparently functional heart.
On the basis of in vitro experiments, it has been suggested
that integrins may play a major role in allowing the G1-
phase cell cycle progression (Assoian, 1997). The involve-
ment of integrins in permitting S phase entry has been high-
lighted by the requirement of adhesion and spreading onto
extracellular matrix for triggering cyclin D1 accumulation
and p27
kip1 decrease (Assoian and Schwartz, 2001). Further-
more, binding to distinct integrin ligands can selectively in-
hibit or promote cell growth (Giancotti, 2000). Neverthe-
less, extracellular matrix adhesion is a complex process in
which several receptors other than integrins may contribute.
The finding of signaling properties for transmembrane mol-
ecules like CD44 and syndecans (Couchman and Woods,
1999) complicates the assignment to integrins of cell matrix
adhesion-triggered signals. Our results in vivo and in pri-
mary cell cultures clearly demonstrated that signaling from
the  1 integrin cytodomain plays a central role in anchorage-
Figure 9. Analysis by confocal microscopy of Erk nuclear accumulation. Cells were seeded on fibronectin in the presence of growth factors 
for 4 h with or without prior infection with Rac
V12 or Rac
N17 adenoviruses. Fixed and permeabilized cells were stained with an anti-Erk1/2 
polyclonal antibody (C-14; Santa Cruz Biotechnology), bisbenzimide, and phalloidin-FITC. Bar, 10  m.In vivo study of a  1 integrin cytodomain mutant | Hirsch et al. 489
dependent cell growth. Consistent with a role of  1 integrin
cytodomain in these processes, inhibitory effects on cell pro-
liferation can be detected after transfection of immortalized
cells with the  1C (Fornaro et al, 1995; Meredith et al.,
1995) or the  1D (Belkin and Retta, 1998) splicing variants.
A requirement for integrin-mediated signal transduction
is the clustering of these molecules into discrete subcellular
domains like focal contacts. The finding that  1de6 integrins
localizes into these districts was unexpected, as other  1 inte-
grin C-terminal tail mutants have been reported to fail to
enter focal adhesions. Nevertheless, similarly to  1de6, the
 1B cytoplasmic domain variant can localize under specific
conditions to a subset of focal contacts (Armulik et al.,
2000). Because studies of  1 integrin cytodomain mutants
have been carried out by transfection of transformed cell
lines, the distribution of  1de6 might be due to a specific be-
havior of primary MEFs. Alternatively, it is conceivable that
specific adaptations allowing homozygous mutant cells to lo-
calize  1de6 in focal contacts were selected during ontogeny.
However, the recruitment of  1de6 in focal adhesions ex-
cludes the possibility that the signaling defects observed in
 1de6 homozygous MEFs were caused by a displacement
from the correct intracellular location. It is interesting to
note that mutant MEFs used for localization experiments af-
ter adhering to fibronectin for 2 h appeared as spread as
wild-type cells. This is in apparent contrast with the im-
paired Rac activation detected in  1de6 homozygous fibro-
blasts. However, the immunofluorescence assays were per-
formed in the presence of growth factors, a condition where
Rac activation in mutant MEFs is decreased but not abol-
ished. Therefore, it is possible that this residual Rac activity
is sufficient to support cell spreading. Nonetheless, consis-
tently with a deficient Rac activation, mutant cell showed a
decreased spreading rate (Barberis et al., 2000) and displayed
a reduced number of lamellipodia after 30 min of fibronec-
tin adhesion.
Analysis of signaling properties of  1de6 homozygous
MEFs showed defective adhesion-triggered FAK, paxillin,
PI3K, Rac, and JNK activation. Chen et al. (1996) have
shown that FAK phosphorylation causes PI3K and PKB/Akt
activation. This signaling pathway has been correlated to the
protection from apoptosis induced by detachment from the
extracellular matrix (anoikis) (Frisch and Ruoslahti, 1997).
Because activated PKB/Akt is known to regulate apoptosis
by phosphorylating pro-apoptotic molecules such as BAD
and caspase 9 (Datta et al., 1999), the increased apoptosis in
 1de6/ 1de6 MEFs might depend on the defective activation
of PI3K/PKB/Akt.
Recently, PI3K has been found to play an essential role
in adhesion-dependent Rac activation in endothelial cells
(Mettouchi et al., 2001). This process is mediated by the
guanine nucleotide exchange factor SOS that, in the pres-
ence of PI3K products, becomes an activator of Rac. How-
ever, it has been reported that in fibroblasts, a second path-
way, requiring interaction of p130Cas, Crk, and DOCK180
plays a prominent role in Rac activation. Because p130Cas is
not activated in  1de6 homozygous MEFs (Barberis et al.,
2000), we could not define the respective contribution of
these two pathways. Nevertheless, the signaling pathway
triggered by p130Cas has central role in promoting matrix-
dependent survival. Adhesion-dependent p130Cas phos-
phorylation and recruitment of Crk trigger antiapoptotic
signals which are relayed by the subsequent activation of Rac
and Jnk (Dolfi et al., 1998). In addition, Almeida et al.
(2000) reported that the Cas-Rac-PAK-MKK4-JNK route is
activated by fibronectin adhesion and promotes survival of
primary fibroblasts. In agreement, the finding that Rac res-
cues  1de6 homozygous MEFs from programmed cell death,
further supports the notion that the FAK-Cas-Rac-JNK
pathway plays a fundamental role in preventing anoikis.
Interestingly, although FAK is not activated in  1de6/ 1de6
MEFS, the lack of FAK in mice results in an embryonic le-
thal phenotype that is much more severe than that of  1de6
homozygotes. FAK-null embryos do not develop beyond 8
dpc and show strong deficits in mesenchymal development
apparently linked to impaired migration of mesodermal cells
(Furuta et al., 1995). The differences in phenotype between
FAK-null and  1de6 homozygotes suggest that the abnormal
adhesion-dependent signaling in  1de6/ 1de6 MEFs likely
does not only depend on the deficit in FAK phosphoryla-
tion. Consistently,  1de6 homozygous MEFs showed a defec-
tive activation of other important signaling pathways, possi-
bly leading to Rac activation such as those arising from
paxillin. The future study of the effects caused by expression
of a dominant positive FAK in  1de6 homozygous MEFs will
be instrumental to address the specific role of FAK in this
system.
Conversely, the rescue of the proliferation defect shown
by  1de6 mutant cells by an activated Rac demonstrated a
central role of this GTPase in anchorage-dependent signal-
ing. Consistent with this finding, Rac activation has been
found to be essential, in endothelial cells, to promote adhe-
sion-dependent Cyclin D1 accumulation and progression
through the G1 phase (Mettouchi et al., 2001). The precise
mechanism by which Rac controls cell cycle progression is
still unclear. Nevertheless, our data indicated that adhesion-
induced Rac activation is necessary for the phosphorylation
of the Rac downstream effector JNK. The role of JNK in
controlling cell proliferation and survival is controversial.
However, several experimental evidences suggest its implica-
tion in the activation of genes involved in cell cycle progres-
sion. For example, fibroblasts lacking the JNK substrate
c-Jun show a severe proliferation defect (Johnson et al.,
1993). Furthermore, adhesion-dependent JNK activation is
necessary for progression through the G1 phase of the cell
cycle (Oktay et al., 1999).
It has been previously shown that  1de6 homozygous
MEFs normally activate Erk in response to a combined stim-
ulation by adhesion and growth factors (Barberis et al.,
2000). However, the results reported here showed that this
event is not sufficient to promote cell cycle progression, and
that other integrin-dependent signals deriving from Rac are
crucially required. The role of adhesion-triggered Erk activa-
tion in cell proliferation is indeed controversial: whereas
Roovers et al. (1999) propose that artificial activation of Erk
in suspended cells can override adhesive requirements for
cell cycle progression, Le Gall et al. (1998) show that these
conditions are not sufficient to induce Cyclin D1 expres-
sion. In addition, recent experiments show that, indepen-
dently from adhesion, Erk phosphorylation per se is not suf-490 The Journal of Cell Biology | Volume 157, Number 3, 2002
ficient for nuclear translocation and activation of the
transcription factor Elk (Aplin et al., 2001). Analysis of Erk
subcellular localization revealed that, after adhesion to fi-
bronectin, homozygous  1de6 MEFs fail to translocate phos-
phorylated Erk into the nuclei. Interestingly, this defect
could be rescued by the expression of a constitutively acti-
vated Rac. Such findings conclusively indicate that Erk nu-
clear translocation requires adhesion-mediated Rac activa-
tion. Further studies will be required to define the precise
biochemical mechanism underlying this process.
At present, the possibility that the substitution of the  1
C-terminal tail by 11 amino acids provided a specific ability
to positively induce the described signaling defects cannot be
formally excluded. However, the chances that the 11 random
amino acids result in an intrinsic signaling activity leading to
FAK-Rac-JNK/Erk inhibition are objectively poor. In fact,
scanning of existing protein domain and human genome da-
tabases failed to indicate any significant homology of the
 1de6–specific sequence to other naturally occurring proteins.
Moreover, the signaling properties of  1de6 are consistent with
what described for several different  1 integrin cytoplasmic
domain mutants (Sastry and Horwitz, 1993). In particular,
the mutant that specifically lacks the alternatively spliced
C-terminal tail, like  1de6, does not activate FAK (Retta et al.,
1998). Finally, the phenotypic rescue by expression of a con-
stitutively active form of Rac further strengthens the hypothe-
sis that the  1de6 mutation causes a loss of function effect, spe-
cifically affecting integrin-mediated signals. In conclusion, the
findings presented here provide a genetic link between the  1
integrin cytoplasmic domain and the adhesion-mediated acti-
vation of Rac, thus supporting the notion that if integrins fail
to trigger signals leading to MAPK activity, cell cycle progres-
sion as well as cell survival are impaired in vivo.
Materials and methods
Generation of  1de6 mutant ES cells and mice
To generate the targeting construct aimed at producing a truncated  1 cy-
toplasmic domain, a 5  homology arm was obtained by PCR amplification
of the intron between murine  1 integrin exon 5 and 6 (1.8 kbp), using two
primers hybridizing to the intron downstream exon 5 (5 -GGAATTCCTC-
GAGCTGAGTCATTGCTGGGGTTC-3 ) and to the end of exon 6 (5 -
GGAATTCATCAGGTGTCCCACTTGGCATTC-3 ), respectively. Stop co-
dons, a PGK polyadenylation sequence, and a neomycin resistance cas-
sette were inserted downstream. The 3  homology arm consisted in a
4-kbp Hind III-Apa I fragment of the murine  1 gene derived from a 129Sv
mouse strain genomic clone. After transfection and selection of G418-
resistant R1 ES cells, homologous recombinants were screened by South-
ern blot, probing XbaI-digested DNA with an Apa I-XbaI genomic fragment
external to the construct. A single clone showing the restriction pattern ex-
pected by the homologous recombination event was microinjected in
C57B6 blastocysts and germ line–transmitting chimeras were used to gen-
erate inbred 129Sv and outbred 129Sv/C57B6 mutant strains.
Characterization of the  1de6 locus and integrin 
expression analysis
Southern blot analysis of  1de6 heterozygous DNA with a neomycin probe
confirmed single copy insertion of the construct but also indicated that the
left arm of the targeting construct had integrated downstream the endoge-
nous exon D (Fig. 2 A). This integration event was confirmed by PCR using
two oligonucleotides corresponding to exon 6 in forward and reverse direc-
tion (P1: 5 -ATTGGGATGATGTCGGGACC-3 ; P2: 5 -AGGCGTGGT-
TGCTGGAATTG-3 ) and the Expand Long Template PCR system (Boeh-
ringer Mannheim) (Fig. 2 C). The amplified fragment was cloned and
sequenced with an ABI-Prism (Perkin Elmer) sequencing machine. The
break-point site was identified by comparing this sequence with the se-
quence of the wild-type intron between exon 5 and 6. These sequences
were used for the design of three oligonucleotides (P3: 5 -CTTATGTC-
CCTATCCTCTGC-3 ; P4: 5 -TCTCCCTAGGTGTTTGTACC-3 ; P5: 5 -
GGCACTTGCTAACAAGACTG-3 ) which allowed mouse genotyping by ge-
nomic PCR. The P3-P4 and P3-P5 couples amplified the  1 wild-type allele
and the  1de6 allele, respectively. RT-PCR experiments (Fig. 2 D) were per-
formed on total RNA of heterozygous ES cells using oligonucleotides located
in exon 5 and 6 (5 -AGGACATTGATGACTGCTGG-3  and P1, respectively).
For the detection of  1A and  1D expression, total RNA was extracted from
10.5-d-old embryos using the RNeasy mini kit (QUIAGEN) and retrotrans-
cribed using random primers (Amersham Pharmacia Biotech). Yolk sacs were
used to genotype the embryo. Oligonucleotides were designed to amplify ei-
ther   1A (P1: 5 -AGGACATTGATGACTGCTGG-3 ; P2: 5 -CGGGATC-
CAAATCCGCCTGAGTAGG-3 ),   1D (P1; P3: 5 -AAACTCAGAGAC-
CAGCTTTAC-3 ) or actin (5 -TCGACATCAGGAAGGACCTGT-3 ; 5 -
GAGGTGGAGTGTGTCTAGAAG-3 ), in a multiplexed reaction consisting of
10 cycles of touch down protocol (annealing from 65 C to 55 C) followed by
17 cycles (95 C 30 s, 55 C 30 s, and 72 C 30 s) for  1A and 19 cycles for  1D.
To detect wild-type and mutant  1 proteins, embryonic fibroblasts were
harvested and washed in Hank’s buffer (1.3 mM CaCl2, 0.4 mM MgSO4, 5
mM KCl, 138 mM NaCl, 5.6 mM D-glucose, 25 mM Hepes, pH 7.4). Cells
were biotinylated at their surface for 30 min at 4 C, washed three times,
lysed in TBS-Triton 0.5%, and centrifuged 10 min. 500  g of extract were
first precipitated with anti- 1A and subsequently with an anti- 1 integrin
recognizing the extracellular domain.
Morphological and histological analysis
Embryos were dissected and fixed in 2% formalin in PBS. Whole-mount
specimens were examined and photographed under the stereomicroscope
(Wild). For histological analysis, the whole decidua or dissected embryos
were fixed in Carnoy’s solution for 4–6 h at 4 C. Paraffin sections (5  m)
were analyzed after haematoxylin-eosin staining.
Analysis of phenotypes in embryonic fibroblasts
For MEF cultures, 9.5-d-old embryos were dissected from maternal tissue
in sterile PBS and individually incubated in trypsin (0.5 ml/embryo). Disso-
ciated tissue was plated in the presence of DME 10% FCS. After 1 wk in
culture, cells were expanded to generate a homogeneous cell population.
For the subsequent experiments mutant and wild-type cells derived for 2–3
embryos were pooled and passaged maximally five times. Assays were
confirmed with at least three different cell populations.
To monitor integrin signaling, cells were deprived of growth factors for
24 h, detached, and washed. The cells were either lysed immediately or
plated on fibronectin 15  g/ml for the indicated times and lysed. Extrac-
tion buffer consisted of 25 mM tris-HCl, pH 7.5, 1% Triton X-100, 150 mM
NaCl, 1 mM Na3VO4, 10 mM NaF, 1 mM Na4P2O7 and 1 mM EDTA. The
Rac pulldown assay was performed as described (Mettouchi et al., 2001).
Immunofluorescence assays and Erk subcellular
localization analysis
MEFs were detached with EDTA 3 mM, washed twice, and replated on fi-
bronectin-coated dishes. After a 4-h adhesion, cells were fixed in 2% para-
formaldehyde (PFA), permeabilized with TBS 0.3%-Triton, blocked with
TBS 5%-BSA, and stained for 1 h with the primary antibody and 45 min
with a rodhamine or fluorescein conjugated secondary antibody. For anal-
ysis of lamellipodia formation, cells were starved for 24 h, detached and
replated as above in the presence of 0.2 FCS and 6.25  g/ml insulin. After
30 min, cells were fixed in 2% PFA, stained with phalloidin-RITC and bis-
benzimide, and photographed. For Erk subcellular localization, MEFs were
starved 24 h in the absence or in presence of adenoviral infection (carrying
V12 or N17 forms of Rac). Cells were detached with EDTA 3 mM, washed
twice and replated on fibronectin coated dishes for 4 h in the presence of
growth factors. Cells were fixed with PFA 2%, permeated with TBS 0.3%-
Triton, blocked with TBS 5%-BSA, stained ON at 4 C with a polyclonal
antibody recognizing Erk (Cat: SC-16; Santa Cruz Biotechnology), washed
again in TBS, and stained for 1 h with a rhodamine-conjugated anti–rabbit
antibody mixed to a fluorescein-conjugated phalloidin. After TBS washing,
cells were incubated 5 min with bisbenzimide (1  g/ml). Fluorescence
was detected using a confocal microscope.
Proliferation and apoptosis assays
For in vivo BrdU labeling, embryos were dissected from maternal tissues at
8.5 and at 9.5 dpc 1 h after intraperitoneal injection of 10  g/g body
weight of 5-bromo-2 -deoxy-uridine (BrdU; Sigma-Aldrich). For cell prolif-In vivo study of a  1 integrin cytodomain mutant | Hirsch et al. 491
eration assays, cells were starved 24 h in absence of serum, detached, and
replated for 8 h on 15  g/ml matrix-coated dishes in the presence of 0.2%
FCS, 6.25  g/ml insulin, and 10  M BrdU. MEFs were fixed with 4% PFA
and stained using the BrdU detection kit II (Roche). For FACS analysis of
DNA content, cells treated as above were stained with propidium iodide
using the Cycle TEST PLUS DNA Reagent Kit (Becton Dickinson). To de-
tect apoptosis, cells or sections of 9.5-dpc embryos were treated in the
same way and analyzed by a TUNEL assay using the In Situ Cell Death De-
tection POD Kit (Roche).
Recombinant adenoviruses and rescue experiments
Recombinant adenoviruses expressing GFP or cDNAs for RAC in constitu-
tively active (V12) and dominant negative (N17) forms were constructed.
Infection of 293 cells was monitored by GFP expression, and when  90%
of the cells were floating, the pellet was freeze thawed three times to liber-
ate the virus. MEFs were infected by 100  l of virus stock generating at
least the infection of 60% of the cells. E1A expression was monitored to
exclude the presence of revertant adenoviruses. GFP-positive infected cells
were analyzed for proliferation and survival as above.
Antibodies
Anti P-Tyr PY20, anti-Src, anti-cleaved Caspase-3, anti-Prodomain of Cas-
pase-3, anti-E1A, anti-p27 and anti-Cyclin D1 were purchased from Santa
Cruz Biotechnology; anti-paxillin, anti-p85, and anti-RAC were purchased
from Transduction Laboratories; and anti-JNK, anti-P-JNK, anti-AKT, anti-
P-AKT, anti-p38, and anti-P-p38 were purchased from New England
Biolabs.
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